Clinical implications of hepatitis G virus (HGV) infection

Clinical Laboratory

Volumn 45, Issue 11-12, 1999, Pages 639-650

  Giménez Barcons, Mireia ^a   Sánchez Tapias, José María ^a   Saiz, Juan Carlos ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INST D INVESTIGACIONS B   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC HEPATITIS; HEPATITIS G VIRUS; HUMAN; REVIEW; VIRUS DETECTION; VIRUS GENOME; VIRUS HEPATITIS; VIRUS TRANSMISSION;

GB VIRUS C/HEPATITIS G VIRUS;

EID: 0032750890     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B hepatitis genome. Science 1989; 244: 359-362.
2. Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321. 1494-1500.
3. Weiner AJ, Kuo G, Bradley DW, et al. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet 1990;335:1-3.
4. Sänchez-Tapias JM, Barrera JM, Costa J, et al. Hepatitis C virus infection in patients with non-alcoholic chronic liver disease. Ann Intern Med 1990; 112: 921-924.
5. Reyes GR, Purdy MA, Kim JP, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990; 247: 1335-1339.
6. Deinhardt F, Holmes AW, Capps RP and Popper H. Studies on the transmission of human viral hepatitis to marmoset monkeys. J Exp Med 1967; 125: 673-687.
7. Simons JN, Pilot-Matias TJ, Leary TP, et al. Identification of two flavivirus-like genomes in GB hepatitis agent. Proc Natl Acad Sci USA 1995; 92: 3401-3405.
8. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1: 564-569.
9. Linnen J, Wages J, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505-508.
10. Leary TP, Muerhoff AS, Simons JN, et al. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996; 48: 60-67.
11. Muerhoff AS, Smith DB, Leary TP, Erker JC, Desai SM and Mushahwar IK. Identification of GB virus C variants by phylogenetic analysis of 5′-untranslated and coding region sequences. J Virol 1997; 71: 6501-6508.
12. Wang HL, Hou YD and Jin DY. Identification of a single genotype of hepatitis G virus by comparison of one complete genome from a healthy carrier with eight from patients with hepatitis. J Gen Virol 1997; 78: 3247-3253.
13. Muerhoff AS, Simons JN, Leary TP, et al. Sequence heterogeneity within the 5′-terminal coding region of the hepatitis GB virus C genome and evidence for genotypes. J Hepatol 1996; 25: 379-384.
14. Pickering JM, Thomas HC and Karayiannis P. Genetic diversity between hepatitis G virus isolates: analysis of nucleotide variation in the NS-3 and putative "core" peptide genes. J Gen Virol 1997; 78: 53-60
15. Simons JN, Desai, SM, Schultz DE, Lemosn SM and Mushahwar IK. Translation initiation in GB viruses A and C: evidence for internal nbosome entry and implications for genome organization. J Virol 1996: 70: 6126-6135.
16. Pickering JM, Thomas HC and Karayiannis P Predicted secondary structure at the 3' end of the HGV 5' UTR consistent with an IRES. J Virol Hep 1997; 4: 175-184
17. Viazov S, Riffelmann M.. Khoudyakov YS, Fieds H, Varenholz C and Roggendorf M. Genetic heterogeneity of hepatitis G virus isolates from different parts of the world. J Gen Virol 1997; 78: 577-581.
18. Khudyakov YS, Cong M, Bonafonte M.T, et al. Sequence variation within a nonstructural region of hepatitis G virus genome. J Virol 1997; 71: 6875-6880.
19. Ibáñez A, Giménez-Barcons M, Tajahuerce A, et al. Prevalence and genotypes of GB virus C/hepatitis G virus (GBV-C/HGV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV) infected patients: evidence of GBV-C/HGV sexual transmission. J Med Virol 1998; 55: 293-299.
20. Giménez-Barcons M, Ibáñez A, Tajahuerce A, et al. Genetic evolution of hepatitis G virus in chronically infected individual patients. J Gen Virol 1998; 79:2623-2629.
21. Fukushi S, Kurihara C, Ishiyama N, et al. Nucleotide sequence of the 5' non-coding region of hepatitis G virus isolated from Japanese patients: comparison with reported isolates. Biochem Biophys Res Comm 1996; 226: 314-318.
22. Okamoto H, Nakao H, Inoue T, et al. The entire nucleotide sequence of two GB virus Cl hepatitis G virus isolates of distinct genotypes from Japan. J Gen Virol 1997; 78: 737-745.
23. Smith DB, Cuceanu N, Davison F, et al. Discrimination of hepatitis G virus/GB virus C geographical variants by analysis of the 5' non-coding region. J Gen Virol 1997; 78: 1533-1542.
24. Bukh J, Kim JF, Govindarajan S, et al. Experimental infection of chimpanzees with hepatitis G virus and genetic analysis of the virus. J Infect Dis 1998; 177: 855-862.
25. Ogata N, Alter HJ, Miller, RH and Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 1991, 88: 3392-3396.
26. Schlueter V, Schmolke S, Stark K, Hess G, Ofenloch-Haehnle B and Engel AM. Reverse transcription-PCR detection of hepatitis G virus. J Clin Microbiol 1996; 34: 2660-2664.
27. Pilot-Matias TJ, Carrick RJ, Coleman PF, et al. Expression of the GB virus C E2 glycoprotein using the Semliki forest virus vector and its utility as a serological marker. Virology 1996; 225: 282-292.
28. Tacke M, Kiyosawa K, Stark K et al. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 1997, 349: 318-320.
29. Feucht HH, Zollner B Polywka S, et al. Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients. Hepatology 1997; 26: 491-494.
30. Tacke M, Schmolke S, Schleuter V, et al. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. Hepatology 1997; 26: 1626-1633.
31. Skidmore S, Collingham KE. Prevalence of GB virus-C/hepatitis G virus infection in an antenatal population. J Med Virol 1999; 57: 235-237.
32. Tan D, Matsumoto A, Conry-Cantilena C, et al. Analysis of hepatitis G virus (HGV) RNA. antibody to HGV envelope protein, and risk factors for blood donors comfected with HGV and hepatitis C virus. J Infect Dis 1999, 179: 1055-61.
33. Wang JT, Tsai FC, Lee CZ, et al. A prospective study of transfusion-transmitted GB virus C infection: similar frequency but different clinical presentation compared with hepatitis C virus. Blood 1996; 88: 1881-1886.
34. Jarvis LM, Davidson, F, Hamley, et al. Infection with hepatitis G virus among recipients of plasma products. Lancet 1996; 348: 1352-1355.
35. Neilson J, Harrison P, Milligan DW, Skidmore SJ, Collingham KE. Hepatitis G virus in long-term survivors of haematological malignancy. Lancet 1996; 347: 1632-1633.
36. Tagariello G, InfantolinoD, Biasin MR, Davoli PG and Traldi A. Hepatitis G viral RNA in Italian hemophiliacs with and without hepatitis C infection. Lancet 1996; 348: 760-761.
37. Skidmore SJ, Collingham KE, Harrison P, et al. High prevalence of hepatitis G virus in bone marrow transplant recipients and patients treated for acute leukemia. Blood 1997; 89: 3853-3856.
38. Masuko K, Mitsui T, Iwano K, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996; 334: 1485-1490.
39. Sampietro M, Badalamenti S, Graziani G, et al. Hepatitis G virus infection in hemodialysis patients. Kidney Int 1997; 51: 348-352.
40. Lamballerie S, Charrel RN and Dussol B. Hepatitis G virus on hemodialysis. N Engl J Med 1996; 334: 1549
41. Tsuda F, Hadiwandowo S, Sawada N, et al. Infection with GB virus C (GBV-C) in patients with chronic liver disease or on maintenance hemodialysis in Indonesia. J Med Virol 1996; 49: 248-252.
42. Forns X, Fernández-LLamas P, Costa J, et al. Hepatitis G virus infection in a hemodialysis unit: prevalence and clinical implications. Nephrol Dial Transpl 1997; 12: 956-960.
43. Aikawa T, Sugai Y and Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med 1996; 334: 195-196.
44. Stark K, Bienzle U, Hess G, Engel AM, Hagenscheid B and Schluter V. Detection of the GB virus C/hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors. J Infect Dis 1996; 174: 1320-1323.
45. Schreirer E, Höhne M, Künkel U, Berg T and Hopf U. Hepatitis GBV-C sequences in patients infected with HCV contaminated anti-D immunoglobulin and among i.v. drugs users in Germany. J Hepatol 1996; 25: 385-389.
46. Nubling CM and Lower J. GB-C genomes in a high-risk group, in plasma pools, and in intravenous immunoglobulin. Lancet 1996; 347: 68.
47. Fiorladisi G, Battinardi A, Zanella Y, Stellini R, and Paraninfo G. Parenteral and sexual transmission of GB virus C and hepatitis C virus among human immunodeficiency virus-positive patients. J Infect Dis 1996; 175: 1025-1026.
48. Wu JC, Sheng, et al. Prevalence and risk factors analysis of GBV-C/HGV infection in prostitutes. J Med Virol 1997; 52: 83-85.
49. Kao JH, Liu CJ, Chen PJ, et al. Interspousal transmission of GB virus C/hepatitis G virus. A comparison with hepatitis C virus. J Med Virol 53: 348-353.
50. Sarrazin C, Roth WK and Zeuzem S. Heterosexual transmission of GB virus C/hepatitis G virus infection. Eur J Gastroenterol Hepatol 1997; 9: 1117-1120.
51. Semprini AE, Perisco T, Thiers V, et al. Absence of hepatitis C virus and detection of hepatitis G virus/GB virus C RNA sequences in the semen of infected men. J Infect Dis 1998; 177: 848-854.
52. Feucht HH, Zöllner B, Polywka S et al. Vertical transmission of hepatitis G virus. Lancet 1996; 347: 615-6.
53. Viazov S, Riffelmann M, Sarr S, et al. Transmission of GBV-C/HGV from drug-addicted mothers to their babies. J Hepatol 1997; 27: 85-90.
54. Fischler B, Lara C, Chen M, et al. Genetic evidence for mother-to-infant transmission of hepatitis G virus. J Infect Dis 1997; 176: 281-285.
55. Menéndez C, Sánchez-Tapias, JM, Alonso P, Giménez-Barcons M. et al. Molecular evidence of mother-to-infant transmission of hepatitis G virus (HGV) among women without known risk factors for parenteral infections. J Clin Microbiol 1999; 37: 2333-2336.
56. Chen M, Wönnerborg A, Johansson B and Sallberg M. Detection of hepatitis G virus (GB virus C) RNA in human saliva. J Clin Microbiol 1997; 35: 973-975.
57. Wang HL and Jin DY. Prevalence and genotype of hepatitis G virus in Chinese professional blood donors and hepatitis patients. J Infect Dis 1997; 175: 1229-133.
58. Saiz JC, Ampurdanès S, Olmedo E, et al. Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon. J Hepatol 1997; 26:787-793.
59. Loiseau P, Manotti M, Corbi C, et al. Prevalence of hepatitis G virus RNA in French blood donors and recipients. Transfusion 1997; 37: 645-650.
60. Roth WK, Waschk D, Marx S, et al. Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients. Transfusion 1997; 37: 651-656.
61. Yoshikawa A, Fukuda S, Itoh K, et al. Infection with hepatitis G virus and its strain variant, the GB agent (GBV-C), among blood donors in Japan. Transfusion 1997; 37: 657-663.
62. Kato T, Mizokami M, Nakano T, et al. High prevalence of GB virus C/hepatitis G virus infection among the Jewish population in Uzbekistan. Vir Res 1997; 48: 81-87.
63. Toshiba M, Okamoto H and Mishiro S. Detection of GBV-C hepatitis virus in serum from patients with fulminant hepatitis of unknown etiology. Lancet 1996; 348: 1131-1133.
64. Alter M, Gallagher M, Morris TT, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 1997; 336: 741-746.
65. Alter HJ, Nakatsuji Y, Melpolder J, et al. The incidence of trans fusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336: 747-754.
66. Hwang SJ, Lu RH, Chan CY, et al. The role of hepatitis G virus infection in patients with acute posttransfusion hepatitis in Taiwan. Gastroenterology 1997; 112: 1260-1264.
67. Heringlake S, Osterkamp S, Trautwein Ch, et al. Association between fulminant hepatic failure and a strain of GB virus C. Lancet 1996; 348: 1626-1629.
68. Panda SK, Panograhi AK, Dasarathy S and Acharya SK. Hepatite G virus in India. Lancet 1996; 348: 1319.
69. Kao JH, Chen PJ and Chen DS. GBV-C in the etiology of fulminant hepatitis. Lancet 1996; 347: 120.
70. Sallie R, Shaw J and Mutimer D. GBV-C virus and fulminant hepatic failure Lancet 1996; 347: 1552.
71. Saiz JC, Sans M, Mas A, et al. Hepatitis G virus infection in fulminant hepatic failure. GUT 1997; 41: 696-699.
72. Tameda Y, Kosaka Y, Tagawa S, et al. Infection with GB virus C (GBV-C) in patients with fulminant hepatitis. J Hepatol 1996; 25. 842-847.
73. Moatter T, Tanq SA, Fisher-Hoch S, Haroon S and Mc Cormick JB. Hepatitis G virus in Karachi, Pakistan. Lancet 1996; 348: 1318-1319.
74. Belli L, Ideo G, Siliru E, et al. Hepatitis G virus and post-transplantation hepatitis. N Engl J Med 1996; 11: 1569-1575.
75. Sugai S, Nakayama H, Fukuda M, et al. Infection with GB virus C in patients with chronic liver disease. J Med Virol 1997; 51: 175-181.
76. Pessoa MG, Terrault NA, Ferrell LD, et al. Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation. Hepatology 1997; 25: 1266-1270.
77. Guilera M, Saiz JC, Lopez-Labrador FX, et al. Hepatitis G virus infection in chronic liver disease. GUT 1998; 42:107-111.
78. Tanaka E, Alter HJ, Nakatsuji Y, et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med 1996; 125: 740-743.
79. Berg T, Dirla U, Naumann U, et al. Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus. J Hepatol 1996; 25: 763-768.
80. Marunot M, Marcellin P, Boyer N, et al. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon alpha in patients with chronic hepatitis C. Ann Intern Med 1997; 126: 874-881.
81. Enomoto M, Nishiguchi S, Fukuda K, et al Characteristics of patients with hepatitis C virus with and without GB virus C/hepatitis G virus co-infection and efficacy of interferon alpha. Hepatology 1998; 27: 1388-1393.
82. Yang G, Caroli-Bosc FX, Laffont C, et al. Hepatitis G and C viruses respond to interferon-alpha with different virological kinetics. Dig Dis Sci 1998; 43: 1307-1310.
83. Giménez-Barcons M, Sánchez-Fueyo A, Puig, F, et al. Selection of hepatitis G virus variants under interferon pressure. Ant. Vir. Ras. (in press).
84. Kao JH, Chen PL, Lai MY, et al. GB virus C/hepatitis G virus infection in an area endemic for viral hepatitis, chronic liver disease, and liver cancer. Gastroenterology 1997; 112: 1265-1270.
85. Parés A, Barrera JM, Caballena J, et al. Hepatitis C virus antibodies in chronic alcoholic patients. Association with severity of liver injury. Hepatology 1990; 12: 1295-1299.
86. Sobue S, Highasi H, Nakao H, et al. Hepatitis G virus infection in patients with alcoholic liver disease. Alcohol Clin Exp Res 1998; 23: 156S-160S.
87. Rodríguez-Agullo JL, Suärez A, Ladero JM, López-Alonso G, et al. Hepatitis G virus infection in Spanish patients with hepatocellular carcinoma. Liver 1998; 18: 255-258.
88. Heringlake S, Tillman HL, Cordes-Temme P, et al. GBV-C/ HGV is not the major cause of autoimmune hepatitis. J Hepatol 1996; 25: 980-984.
89. Bréchot C, Jaffredo F, Lagorce D, et al. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action. J Hepatol 1998; 29: 173-183.
90. Müller C, Pfeffel F, Peck-Radosavljevic M, Petermann D, et al. Prevalence of hepatitis G virus in patients with hepatocellular carcinoma. J Viral Hepat 1997; 4: 411-414.
91. Fried NW, Khudyakov YE, Smallwood GA, et al. Hepatitis G virus coinfection in liver transplantation recipients with chronic hepatitis C and nonviral chronic liver disease. Hepatology 1997, 25: 1271-1275.
92. Cotler SJ, Gretch DR, Bronner MP, et al. Hepatitis G virus co-infection does not alter the course of recurrent hepatitis C virus infection in liver transplantation recipients. Hepatology 1997; 26: 432-436.
93. Berenguer M, Terrault NA, Piatak M, et al. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology 1996; 111: 1569-1575.
94. Dickson RC, Qian KP, Lau JY, et al. High prevalence of GB virus C/hepatitis G virus infection in liver transplant recipients. Transplantation 1997; 63: 1695-1697.
95. Abe K, Edamoto Y, Park Nyun Y, et al. In situ detection of hepatitis B, C and G virus nucleic acids in human hepatocellular carcinoma tissues from different geographic regions. Hepatology 1998; 28: 568-572.
96. Madejon A, Fogeda M, Bartolomé J, et al. GB virus C RNA in serum, liver, and peripheral blood mononuclear cells from patients with chronic hepatitis B, C and D. Gastroenterology 1997; 113: 573-8.
97. Saito S, Tanaka K, Kondo M, et al. Plus- and minus-stranded hepatitis G virus RNA in liver tissue and in peripheral blood mononuclear cells. Biochem Biophys Res Comm 1997; 237: 288-91.
98. Laras A, Zacharakis G, Hadziyannis SJ. Absence of the negative strand of GBV-C/HGV RNA from the liver. J Hepatol 1999; 30: 383-388.
99. Laskus T, Radkowski M, et al. Detection of hepatitis G virus replication sites by using highly strand-specific Tth-based reverse transcriptase PCR. J Virol 1998; 72: 3072-3075.
100. Radkowski M, Wang LF, Cianciara J, Rakela J and Laskus T. Analysis of hepatitis G virus/GB virus C quasispecies and replication sites in human subjects. Biochem and Biophys Res Comm 1999; 258: 296-299.
101. Lefrère JJ, Roudot-Thoraval F, Morand-Joubert L, et al. Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis 1999; 179: 783-9.
102. Heringlake S, Ockenga J, Tillman HL, et al. GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus- infected patients? J Infect Dis 1998; 177: 1723-6.
103. Rey D, Fraizie S, Vidinic J, et al. High prevalence of GB virus C/hepatitis G virus RNA in patients infected with human immunodefieciency virus. J Med Virol 1999; 57: 75-79.
104. Toyoda H, Fukuda Y, Hayakawa T, et al. Effect of GV virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17: 209-13.
105. Alter HJ. G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus. Trans fusion 1997; 37: 569-72.
106. Blair SC, Davidson F, Lycett C, et al. Prevalence, incidence and clinical characteristics of hepatitis G virus/GB virus C infection in Scottish blood donors. J Infect Dis 1998; 178: 1779-82.